International Journal of Cardiovascular ResearchISSN: 2324-8602

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, Int J Cardiovasc Res Vol: 4 Issue: 4

Statin Therapy is Associated with Reduction of Epicardial Adipose Tissues and Coronary Plaque Volumes with Vulnerable Composition, Measured by Computed Tomography Angiography

Naser Ahmadi*, Vahid Nabavi, Jennifer Malpeso, Fereshteh Hajsadeghi, Hussain Ismaeel and Matthew Budoff
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center,Torrance, California, USA
Corresponding author : Naser Ahmadi, MD
David Geffen School of Medicine,UCLA, 1124 W. Carson Street, RB3, Torrance, CA, 90503, USA
Tel: +310-803-0443
E-mail: drnaserahmadi@gmail.com
Received: January 30, 2015 Accepted: April 27, 2015 Published: April 29, 2015
Citation: Ahmadi N, Nabavi V, Malpeso J, Hajsadeghi F, Ismaeel H, et al. (2015) Statin Therapy is Associated with Reduction of Epicardial Adipose Tissues
and Coronary Plaque Volumes with Vulnerable Composition, Measured by Computed Tomography Angiography. J Cardiovasc Res 4:4. doi:10.4172/2324-8602.1000216

Abstract

 Statin Therapy is Associated with Reduction of Epicardial Adipose Tissues and Coronary Plaque Volumes with Vulnerable Composition, Measured by Computed Tomography Angiography

Background: Increased coronary plaque volume and epicardialadipose-tissue (EAT) are independently predicting major-adversecardiovascular-events. This study evaluates the changes in EAT, total and composition-specific plaque-volume measured noninvasively by computed-tomography-angiography (CTA) in subjects with and without statin-therapy. Methods: This is a study of 106 consecutive-subjects (age 67 ± 9years, 80.7% men) who underwent serial clinically-indicated CTAs with median-interval of 1.2-year. Clinical and demographicfindings of 31 with statin-therapy and 75 without statin-therapy were evaluated. Changes in indexed total and composition-specific plaque-volume of target-segment with luminal-stenosis <50% as well as EAT, adipose-tissue inside pericardial-sac, were measured quantitatively. Results: At baseline, there was no significant difference in EAT, total and composition-specific plaque-volumes among subjects with and without statin-therapy (p>0.05). At follow-up, there were significant absolute-decrease in total plaque-volume (-38.2%) and EAT (-18.4%) in individuals with statin-therapy as compared to those without statin-therapy (p=0.0001). Similarly, significant decrease in non-calcified and mixed plaque-volume as well as lack of progression of calcified plaque-volume in statin-therapy group was noted (p<0.05). Risk adjusted median-decrease in total, mixed, calcified, non-calcified plaque-volumes, and EAT were 56%, 12%, 43%,144% and 76% more in statin-therapy as compared to those with diet-therapy (p<0.05). Furthermore, a significant directcorrelation between decrease in LDL-C and reduction in noncalcified plaque-volume (r2=0.64,p=0.0001) and decrease in EAT and non-calcified plaque-volume was noted (r2=0.69,p=0.0001). Conclusions: Statin therapy is associated with concomitant decreases in LDL-C, EAT and coronary plaque volumes especially non-calcified and mixed coronary plaques, which the latter suggesting plaque stabilization. This highlights that CTA can accurately and quantitatively measure the changes in EAT and coronary plaque volumes over time and monitor response to therapies.

Keywords: Coronary plaque volume; Computed tomography angiography; Statin-therapy; Plaque composition; Epicardial adipose tissue

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination

Media Partners

open access